As of October 15, 2025, Provexis PLC has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.62, this represents a potential upside of -265.4%.
| Key Metrics | Value |
|---|---|
| DCF Fair Value (5-year) | $0.00 |
| DCF Fair Value (10-year) | $0.00 |
| Potential Upside (5-year) | -233.8% |
| Potential Upside (10-year) | -265.4% |
| Discount Rate (WACC) | 5.4% - 7.0% |
Revenue is projected to grow from $1 million in 03-2024 to $2 million by 03-2034, representing a compound annual growth rate of approximately 7.2%.
| Fiscal Year | Revenue (USD millions) | Growth |
|---|---|---|
| 03-2024 | 1 | 106% |
| 03-2025 | 1 | 12% |
| 03-2026 | 1 | 2% |
| 03-2027 | 1 | 5% |
| 03-2028 | 1 | 5% |
| 03-2029 | 1 | 8% |
| 03-2030 | 1 | 10% |
| 03-2031 | 1 | 7% |
| 03-2032 | 1 | 5% |
| 03-2033 | 1 | 7% |
| 03-2034 | 2 | 10% |
Net profit margin is expected to improve from -73% in 03-2024 to -47% by 03-2034, driven by operational efficiency and economies of scale.
| Fiscal Year | Net Profit (USD millions) | Profit Margin |
|---|---|---|
| 03-2024 | (1) | -73% |
| 03-2025 | (1) | -52% |
| 03-2026 | (1) | -51% |
| 03-2027 | (1) | -51% |
| 03-2028 | (1) | -51% |
| 03-2029 | (1) | -49% |
| 03-2030 | (1) | -49% |
| 03-2031 | (1) | -48% |
| 03-2032 | (1) | -48% |
| 03-2033 | (1) | -47% |
| 03-2034 | (1) | -47% |
with a 5-year average of $0 million. Projected CapEx is expected to maintain at approximately 0% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
| Fiscal Year | D&A (USD millions) |
|---|---|
| 03-2025 | 0 |
| 03-2026 | 0 |
| 03-2027 | 0 |
| 03-2028 | 0 |
| 03-2029 | 0 |
| 03-2030 | 0 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
| Components | Average Days |
|---|---|
| Days Receivables | 5 |
| Days Inventory | 676 |
| Days Payables | 95 |
| Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
|---|---|---|---|---|---|
| 6M/2025 | (0) | (0) | 0 | 0 | (1) |
| 2026 | (1) | (0) | 0 | 0 | (1) |
| 2027 | (1) | (0) | 0 | (0) | (0) |
| 2028 | (1) | (0) | 0 | 0 | (1) |
| 2029 | (1) | (0) | 0 | (0) | (1) |
| Valuation Method | Fair Price (USD) | Potential Upside |
|---|---|---|
| 5-Year DCF (Growth) | 0.00 | -233.8% |
| 10-Year DCF (Growth) | 0.00 | -265.4% |
| 5-Year DCF (EBITDA) | 0.00 | -100.0% |
| 10-Year DCF (EBITDA) | 0.00 | -100.0% |
Is Provexis PLC (PXS.L) a buy or a sell? Provexis PLC is definitely a sell. Based on our DCF analysis, Provexis PLC (PXS.L) appears to be overvalued with upside potential of -265.4%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.62.